Chartwell RX LLC

Congers, NY

UEI
ER5UA9TYBGH4
CAGE
8APG0
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
77 Brenner Dr, Congers, NY 10920, USA
Founded
2010
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $28,078,990
FY2025 $115,144,505
FY2024 $710,034
FY2023 $9,325,637

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $27,199,512
2 Defense Logistics Agency $879,478

Contract vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Chartwell RX LLC, a for-profit pharmaceutical manufacturer and distributor based in Congers, New York, operates as a prime contractor supplying branded and generic medications to federal defense and civilian health agencies, with no subcontractor presence in its federal portfolio. The company competes in full-and-open procurements with no set-aside designations across its award footprint.

Chartwell RX's customer concentration is heavily skewed toward the Defense Logistics Agency Troop Support Medical, which accounts for 792 of 798 total awards (100% coverage) but represents only $10.1 million in combined potential value — the core business is rapid-turnaround, high-volume delivery orders for individual medications at sub-thousand-dollar unit prices. By dollar value, the company's exposure pivots dramatically to two larger civilian contracts: a $449.4 million award from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (one award) and $340.3 million across five awards from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The HHS ASPR contract is a $21.9 million definitive contract awarded September 30, 2026, for bulk pharmaceutical procurement supporting Strategic National Stockpile warehouses, running through September 2027. The VA award appears to represent a single, multi-year supply vehicle of comparable scale.

Chartwell RX's product portfolio centers on oral medications including ondansetron (antiemetic), doxycycline hyclate (broad-spectrum antibiotic), clarithromycin and other macrolides, and terbinafine (antifungal). The company holds seat on Indefinite Delivery Contract SPE2D020D0005 with the Defense Logistics Agency, against which it has issued 791 task orders totaling $3 million in combined potential value. Most DLA task orders are delivery orders for 30 to 1,000-unit batches of single medications, awarded and completed within one to three business days, with firm fixed-price ceilings ranging from five dollars to $17,065. This pattern reflects DLA Troop Support Medical's just-in-time procurement model for military treatment facility pharmaceutical supply.

Activity has grown steadily — 105 awards in 2022 to 200 in 2026 — but the growth is almost entirely in DLA delivery-order volume rather than contract value. Within the next twenty-four months, two awards totaling $22.6 million reach ultimate completion, representing limited recompete exposure for a vendor whose core DLA business turns on continuous new delivery orders issued against standing indefinite delivery vehicles. The company entered federal contracting in March 2020 and established early traction with DLA; the recent HHS ASPR award and VA vehicle indicate expansion into civilian stockpile and health-system supply channels alongside the defense logistics footprint.

Quick answers

Is Chartwell RX LLC registered in SAM.gov?

Yes. Chartwell RX LLC's SAM.gov registration is active through November 23, 2026.

Which contract vehicles does Chartwell RX LLC hold?

Chartwell RX LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

How much has Chartwell RX LLC received in federal contracts?

Federal contracts obligated $115,144,505 to Chartwell RX LLC in fiscal year 2025 and $153,259,166 in fiscal years 2023 through 2027.

How does Chartwell RX LLC rank among federal contractors?

Chartwell RX LLC ranked #4 in NAICS 325412, #6 in NAICS 3254 and #7 in PSC 6505 in FY2025.

What is Chartwell RX LLC's most recent federal award?

Chartwell RX LLC's most recent federal contract award is Bulk pharmaceutical buy for SNS warehouses (chartwell RX, LLC) (75A50326C00010), from Office of the Assistant Secretary for Preparedness and Response, on September 30, 2026.

On GovTribe

See Chartwell RX LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors